Heart Disease News and Research

Latest Heart Disease News and Research

To ban or not to ban, the case for reformulating ultra-processed foods

Despite concerns about ultra-processed foods (UPFs) and non-communicable diseases (NCDs), evidence of causality remains unclear; reformulating UPFs may offer significant health advantages.

1 Apr 2024

AI deciphers city designs that could cut heart disease rates

AI models analyzing over half a million Google Street View images uncover urban features linked to coronary heart disease, offering insights for city design to lower disease rates.

1 Apr 2024

UVA researchers discover Y chromosome gene linked to heart failure in men

University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men.

1 Apr 2024

Childhood BMI tied to higher blood pressure in middle age

Children and teenagers living with overweight or obesity are more likely to have high blood pressure as adults (aged 50-64 years), suggesting the processes behind the condition could begin as early as childhood, suggests new research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May).

1 Apr 2024

Heavy drinkers who cut back see major heart health benefits, study finds

Study shows that heavy drinkers who reduced their alcohol intake experienced a significantly lower risk of major adverse cardiovascular events, underscoring the potential benefits of alcohol reduction on heart health.

31 Mar 2024

Space travel alters human vascular cell function, study finds

Study investigates the transcriptomic changes in human vascular smooth muscle cells exposed to spaceflight, revealing significant alterations in gene expression affecting cellular function and phenotype.

31 Mar 2024

Research identifies optimal body weight to reduce cardiovascular risk in diabetes patients

New research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimize their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease.

30 Mar 2024

Vegan diet benefits individuals with type 1 diabetes, study shows

A low-fat vegan diet rich in fruits, vegetables, grains, and beans reduces insulin needs and improves insulin sensitivity and glycemic control in people with type 1 diabetes, according to a first-of-its-kind study by the Physicians Committee for Responsible Medicine published in Clinical Diabetes.

29 Mar 2024

Polypills prove effective in reducing cardiovascular disease and mortality

A new study from researchers at Washington University Medical School in St. Louis bolsters previous findings that polypills are beneficial in preventing heart attacks and strokes and reducing deaths among people with cardiovascular risk factors, including high blood pressure and high cholesterol.

29 Mar 2024

Research highlights health risks posed by 2,6-DHNPs in drinking water

2,6-DHNPs, a group of disinfection byproducts (DBPs), are raising alarm bells for public health. These bad actors in the water world are tougher and more toxic than many other pollutants, making it hard for typical water cleaning methods to get rid of them.

29 Mar 2024

Study examines meat consumption's impact on mortality risk in the frail

How meat consumption influences the risk of death in frail populations.

29 Mar 2024

Having a ruff day? Study says spending time with dogs can help

How interacting with dogs affects the emotions and psychophysiology of humans using an electroencephalogram.

29 Mar 2024

Study reveals obesity's link to increased risk of multiple sclerosis and ischemic stroke

The genetic relationship between body mass index (BMI) and multiple neurological diseases.

29 Mar 2024

Sit less, live healthier: Trial shows blood pressure drops with less sitting

Whether reducing sitting time could effectively improve blood pressure (BP) among older adults.

29 Mar 2024

An ActRIIA fusion protein got FDA approved for PAH treatment

On March 26th, the US FDA granted approval for Merck’s WINREVAIR™ (sotatercept-csrk), marking a significant milestone in pulmonary arterial hypertension (PAH) treatment. PAH, characterized by elevated blood pressure in the arteries connecting the heart and lungs, poses a grave risk of heart failure.

From Sino Biological Inc. 28 Mar 2024